tiprankstipranks
Intellia Therapeutics (NTLA)
NASDAQ:NTLA

Compare Intellia Therapeutics (NTLA) vs. Competitors

4,705 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Intellia Therapeutics
$13.87
$1.64B
-2.54
120.86%
8 Buy
8 Hold
1 Sell
Moderate Buy
Kura Oncology
$8.79
$776.42M
-3.27
56.41%
9 Buy
1 Hold
0 Sell
Strong Buy
Compass Therapeutics
$5.31
$972.47M
-12.74
239.62%
9 Buy
0 Hold
0 Sell
Strong Buy
AbCellera Biologics
$3.43
$1.04B
-6.98
77.72%
4 Buy
0 Hold
0 Sell
Strong Buy
Janux Therapeutics Inc
$14.93
$883.88M
-7.53
-38.92%
13 Buy
1 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$21.29
$1.41B
-6.67
130.63%
8 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NTLA
Intellia Therapeutics
13.87
6.79
95.90%
KURA
Kura Oncology
8.79
2.82
47.24%
CMPX
Compass Therapeutics
5.40
3.65
208.57%
ABCL
AbCellera Biologics
3.43
1.26
58.06%
JANX
Janux Therapeutics Inc
14.53
-12.30
-45.84%
BCAX
Bicara Therapeutics Inc.
21.61
11.21
107.79%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts